Management of Heart Failure

You might also like

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 35

MANAGEMENT OF HEART

FAILURE

Prof R Moulds
Internal Medicine
FSM Modified 2009 by Dr. Mai Ling Perman
Overview
 Definition
 Pathophysiology
 Underlying causes of heart failure
 Precipitating causes of heart failure
 Diagnosis and differential diagnosis
 Prognosis
 Management
 Drug treatment
 Surgical treatment
Definition
 “The pathophysiological state in which an
abnormality of cardiac function is responsible for
the failure of the heart to pump blood at a rate
commensurate with the requirements of
metabolising tissues.”
Pathophysiology
 Reduction in cardiac output leads to:
 Reduced organ blood flow - particularly renal blood
flow
 Reduced blood pressure
 These stimulate compensatory mechanisms
 Renin - angiotensin system, leading to sodium (and
water) retention and also vasoconstriction
 Sympathetic nervous system.
Pathophysiology (cont)
 These cause an increase in both preload (due to the
fluid retention) and afterload (due to the increase in
blood pressure) of the heart.
 The increase in preload stretches the myocardium,
leading to increased contractility (Starling’s law)
 The increase in afterload also increases myocardial
contractility, as does also the increased sympathetic
nervous activity
Pathophysiology (cont)
 Cardiac output is therefore restored, but at the
expense of an increase in venous pressure (caused
by the fluid retention) and a tachycardia (caused by
the sympathetic stimulation)
Pathophysiology
Underlying causes of heart failure
 Rheumatic valvular disease
 Coronary artery disease (ischaemic heart disease)
 Hypertension (both acute and chronic)
 Congenital heart disease
 Others
 Cardiomyopathies
 Myocarditis
Precipitating causes of heart failure
 Anaemia
 Arrhythmia
 Myocardial infarction
 Pulmonary embolus
 Hypertension (acute)
 Infection
 Thyrotoxicosis
Diagnosis
 Does the patient have heart failure?
 If so, what is the underlying cause?
 In addition to the underlying cause, is there a
precipitating cause?
Diagnosis of heart failure - key features

 Raised venous pressure


 Right sided -> peripheral oedema (swelling of the
ankles, ascites etc)
 Left sided -> pulmonary oedema (shortness of breath)
 Enlargement of the heart
 Tachycardia
Diagnosis - History
 Of failure
 Shortness of breath
 On exercise
 Orthopnoea
 Paroxysmal nocturnal dyspnoea
 Swelling of the ankles
 improves at night
 Swelling of the abdomen (ascites)
Diagnosis – History
 Of cause and/or precipitating factors
 Past history
 ?known valvular disease
 ?known ischaemic heart disease
 ?known hypertension
 Chest pain
 Weakness and tiredness (?anaemia)
 Palpitations
 Thyroid disease
Diagnosis – physical examination
 Of failure
 Raised venous pressure
 Jugular veins assessed and vertical height of column of blood above
the right atrium estimated (normal 0-5 cm)
 hepatomegaly
 Cardiac enlargement – displaced apex beat
 Extra heart sounds – H3, H4, gallop rhythm
 Peripheral pitting oedema
 Crackles at the lung bases
 Other signs of excessive fluid retention
 Ascites
 Pleural effusions
Diagnosis – physical examination
 Of cause and/or precipitating factors
 Heart murmurs
 Valvular disease
 Congenital heart disease
 Hypertension
 Pallor (?anaemia)
 ?arrhythmia
 ?signs of thyroid disease
Diagnosis – investigations (to confirm
failure and to seek cause)
 Chest Xray
 Cardiomegaly
 Pulmonary venous congestion/oedema
 Abnormal cardiac contour
 ECG
 Rhythm
 ischaemic changes
 Chamber hypertrophy
 Echocardiography
 Valve function
 Chamber enlargement
 Thickened ventricular wall/regional wall motion abnormality
 Left ventricular ejection fraction
Investigations
 Chest Xray
Diagnosis – investigations (cont)
 Full blood count
 Renal function tests and electrolytes
 (Thyroid function tests)
 (liver function tests, including serum albumin)
Differential diagnosis
 Other causes of shortness of breath
 Asthma/COPD
 Other respiratory diseases
 Pleural effusion
 Infection – acute (eg pneumonia) or chronic (eg
bronchiectasis, TB)
 Infiltrative lung diseases
Differential diagnosis (cont)
 Other causes of oedema and/or ascites
 Nephrotic syndrome
 Chronic liver disease
 Malignant ascites
 Venous obstruction
 Inferior vena cava
 Bilateral varicose veins
 Severe hypoalbuminaemia
Prognosis
 Depends mainly on the underlying cause, and in
particular on whether or not it is curable/treatable
 Hypertension – good prognosis
 Valvular disease
 Correctable by surgery – good prognosis
 Not correctable by surgery – bad prognosis
 Ischaemic heart disease
 Correctable with surgery – reasonable prognosis
 Not correctable with surgery – bad prognosis (death within ~one
year)
Management - general
 Treat the failure
 Salt restriction, lifestyle changes
 Drugs
 Diuretics
 ACE inhibitors
 Digoxin
 (Beta – blockers)
 Treat underlying causes where possible
 Treat precipitating causes where possible
 Prevent complications, eg emboli
Drug treatment of failure
 Usually commence with a diuretic
 Thiazide in mild cases – relieves symptoms
 Frusemide in more severe cases
 Spironolactone has been shown to improve prognosis in
severe cases
 Use ACE Inhibitor (or A2 antagonist) early in
treatment
 These drugs have been shown to increase life expectancy as
well as improve symptoms
Drugs (cont)
 Digoxin is still a useful drug
 Particularly if the patient is in atrial fibrillation (a common
arrhythmia)
 Also has been shown to be of some benefit in patients with
severe heart failure and sinus rhythm
 Difficult drug to use because of adverse effects
 Beta blockers are now used, because they have been
shown to prolong life. However they can make
failure worse when first commenced
Monitoring therapy
 Improvement of symptoms
 Improvement in physical signs
 Daily weighing (if in hospital and oedematous)
 Improvement in investigational findings e.g. Chest
Xray
Other aspects of drug treatment
 Note that the drugs are reversing the body’s
compensating mechanisms
 So the patient goes back to having reduced blood flow to
the kidneys, and renal function deteriorates with treatment
 Treatment also alters electrolytes – particularly
potassium
 Therefore monitor renal function and electrolytes
Other aspects of drug treatment (cont)
 Anticoagulation
 Some patients with heart failure are in danger of
systemic emboli from blood clots forming within the
heart (usually the left atrium)
 Valvular disease – particularly mitral valve
 Atrial fibrillation

 These patients may need long term anticoagulation


to prevent emboli
Other aspects of drug treatment (cont)
 Underlying cause might need long term drug
treatment
 Ischaemic heart disease
 Aspirin
 Statin
 Hypertension
 Drugs for failure also treat hypertension
 Penicillin prophylaxis for rheumatic valvular heart
disease
Surgical treatment
 Some causes of heart failure can be treated
surgically, depending on the individual situation
 Coronary artery bypass/angioplasty
 Valve replacement or other operation to improve valve
function
 (Removal of ventricular aneurysm)
Summary
 Heart failure is a common clinical syndrome
 The diagnosis of heart failure is made from the
history, physical examination, and with appropriate
investigations
 We must look for, and treat where possible, the
underlying cause and precipitating causes
 Drug treatment is the mainstay of management in the
majority of patients.

You might also like